Core Neuro Division



Deep Brain Stimulation works by electrically stimulating targeted structures in the brain - the subthalamic nucleus (STN) or globus pallidus interna (GPi) - that control movement and muscle function. A lead with tiny electrodes is surgically implanted in the brain and connected by an extension that lies under the skin to a neurostimulator implanted near the collarbone. The electrical stimulation can be non-invasively adjusted to meet each patient's individual needs.
For more information, visit www.medtronic.com
OVERVIEW

Neuromodulation and Spinal Business Overview
Our neurological products include neurostimulation systems, drug delivery systems, neurosurgical implant devices, surgical access products, and diagnostic and therapeutic systems for chronic pain and neurologic, urologic, and gastrointestinal disorders. Eight businesses within our division work together to apply our therapies and products to provide comprehensive solutions to significant neurological disorders.

Medtronic Neurosurgery is committed to providing superior products for the Cranial Neurosurgery market. These products include a wide variety of PS Medical® silicone elastomer valves, catheters, and shunts for hydrocephalus management; external drainage products for the treatment of traumatic brain injury and invasive monitoring; neuroendoscopes for improved surgical access; repair of congenital or traumatic cranial defects; and cranial closure products for quick and secure reattachment of skull flaps.

Deep Brain Stimulation
works by electrically stimulating targeted structures in the brain - the subthalamic nucleus (STN) or globus pallidus interna (GPi) - that control movement and muscle function. A lead with tiny electrodes is surgically implanted in the brain and connected by an extension that lies under the skin to a neurostimulator implanted near the collarbone. The electrical stimulation can be non-invasively adjusted to meet each patient's individual needs.

Medtronic Pain Therapies™ encompass pain management therapies from our neurostimulation and drug delivery areas. Both Neurostimulation and Intrathecal Drug Delivery can be effective options for patients with pain who are experiencing inadequate pain relief or uncomfortable side effects from their current pain treatments.

The Medtronic ITB TherapySM (Intrathecal Baclofen Therapy)
Patient Assistance Program helps eligible people obtain the drug Lioresal® Intrathecal (baclofen injection: 10 mg/20 mL, 10 mg/5 mL, 0.05 mg/1mL) that is used in ITB Therapy. The program is a source of last resort for people whose federal, state and private health insurance resources do not cover the drug component cost of the therapy.

Intrathecal Baclofen (ITB™) Therapy eases intractable spasticity in patients with CP, traumatic brain injury, and stroke by delivering Lioresal Intrathecal (baclofen injection) directly to the intrathecal space in small, precisely controlled doses using a pump that is surgically placed.


SynchroMed EL® and Synchromed II Infusion Systems

Overview
The SynchroMed technology offers a fully implantable and programmable method of continuous drug delivery. In use clinically since 1982, and commercially since 1988, the programmability of the SynchroMed system allows:
· Dosages to be varied throughout the day and tailored to match your individual medication needs.
Non-invasive dose changes. 

Activa® Tremor Control Therapy utilizes an implanted neurostimulation system to stimulate targeted nulcei in the thalamus to suppress tremor associated with Parkinson's disease and essential tremor. Stimulation can be non-invasively adjusted to meet each patient's needs. Activa Therapy is the first completely new approach to controlling tremor in more than 30 years.






ITB Therapy
Deep Brain Stimulation
The Medtronic ITB TherapySM (Intrathecal Baclofen Therapy) Patient Assistance Program helps eligible people obtain the drug Lioresal® Intrathecal (baclofen injection: 10 mg/20 mL, 10 mg/5 mL, 0.05 mg/1mL) that is used in ITB Therapy. The program is a source of last resort for people whose federal, state and private health insurance resources do not cover the drug component cost of the therapy.

SynchroMed EL® and Synchromed II Infusion Systems

Overview
The SynchroMed technology offers a fully implantable and programmable method of continuous drug delivery. In use clinically since 1982, and commercially since 1988, the programmability of the SynchroMed system allows:
· Dosages to be varied throughout the day and tailored to match your individual medication needs.
Non-invasive dose changes.
For Spine Division, (click here)
Spine    |    Core Neuro